Lizzy wrote:i just have the concern that as a personalized medication Tovaxin is obviously going to be very expensive to administer - so for it to make it to the market i would think it would need to have phenomenal results, my fingers are crossed on this one - but i don't know of another "personalized" vaccine out there that has been approved - does anyone else know of one?
ljm wrote:I'm wondering whether I should ask for a more thorough exam, no one has ever suggested an EDSS level for me, I assumed I wasn't even on the scale. Are you sure, err, that there wasn't an effort to find a higher EDSS than might otherwise have been noted? (I'm assuming neuros were part of clinic selected for trial)
notasperfectasyou wrote:Did the boards get this interested as Aimspro was headed towards phase III? I'm wanting to get a gauge on the amount of anticipation and hope when compared to Aimspro.
We now have 12-month data from our two earlier studies, which indicate that the patients treated had a greater than 90% annualized relapse rate reduction, as compared with their prior history.
Users browsing this forum: EricDrake